© 2020 MJH Life Sciences and Cancer Network. All rights reserved.
Author | David J. Kerr, CBE, MD, DSC, FRCP, FMEDSCI
Articles
Capecitabine/Irinotecan Combination Regimens in Colorectal Cancer
April 01, 2002
Capecitabine (Xeloda) and irinotecan (CPT-11, Camptosar) both have demonstrated single-agent activity in patients with colorectal cancer.